Clinical Trials Browser

OTHER × belinostat × 90 days × Clear all

NCT05154994 2026-05-07

RESOLVE

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

NCT05170334 2026-04-06

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Phase 2 Active not recruiting

Uveal Melanoma, Eye Neoplasms